Ignite Creation Date:
2024-05-06 @ 8:00 PM
Last Modification Date:
2024-10-26 @ 3:18 PM
Study NCT ID:
NCT06213636
Status:
RECRUITING
Last Update Posted:
2024-04-09
First Post:
2024-01-10
Brief Title:
Fourth-gen CAR T Cells Targeting CD19CD22 for Highly Resistant B-cell LymphomaLeukemia PMBCLCNS-BCL
Sponsor:
Essen Biotech
Organization:
Essen Biotech
Organization Data
Organization:
Essen Biotech
Class:
OTHER
Study ID:
ESBI202491
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Essen Biotech
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None